Publicacións en colaboración con investigadores/as de Hospital Universitario de Valladolid (10)

2024

  1. Ramipril After Transcatheter Aortic Valve Implantation in Patients Without Reduced Ejection Fraction: The RASTAVI Randomized Clinical Trial

    Journal of the American Heart Association, Vol. 13, Núm. 19, pp. e035460

2022

  1. Chronic use of renin–angiotensin–aldosterone inhibitors in hypertensive COVID-19 patients: Results from a Spanish registry and meta-analysis

    Medicina Clinica, Vol. 158, Núm. 7, pp. 315-323

  2. Differences Between Takotsubo and the Working Diagnosis of Myocardial Infarction With Nonobstructive Coronary Arteries

    Frontiers in Cardiovascular Medicine, Vol. 9

  3. Rationale and design of the Dapagliflozin after Transcatheter Aortic Valve Implantation (DapaTAVI) randomized trial

    European Journal of Heart Failure, Vol. 24, Núm. 3, pp. 581-588

  4. Transcatheter versus surgical aortic valve replacement in patients with morbid obesity: a multicentre propensity score-matched analysis

    EuroIntervention : journal of EuroPCR in collaboration with the Working Group on Interventional Cardiology of the European Society of Cardiology, Vol. 18, Núm. 5, pp. e417-e427

2021

  1. Impact of statins in patients with COVID-19

    Revista Espanola de Cardiologia, Vol. 74, Núm. 7, pp. 637-640

  2. Impact of the presence of heart disease, cardiovascular medications and cardiac events on outcome in COVID-19

    Cardiology journal, Vol. 28, Núm. 3, pp. 360-368

  3. The COVID-19 lab score: an accurate dynamic tool to predict in-hospital outcomes in COVID-19 patients

    Scientific Reports, Vol. 11, Núm. 1

2020

  1. Ramipril in High-Risk Patients With COVID-19

    Journal of the American College of Cardiology, Vol. 76, Núm. 3, pp. 268-276

2013

  1. The Ibero-American transcatheter aortic valve implantation registry with the CoreValve prosthesis. Early and long-term results

    International Journal of Cardiology, Vol. 169, Núm. 5, pp. 359-365